Company intelligence / Profile preview

Eurocrit Labs International

Baddi, Himachal Pradesh, India

Ownership: Private
Development stage: Other

Overview

Eurocrit Labs International manufactures and supplies a wide range of injectable medicines and respules (inhalation solutions), including ciprofloxacin, levofloxacin, dextrose, budesonide, and salbutamol. Products are marketed via third-party arrangements and are distributed for both branded and unbranded pharmaceutical clients in India. The company claims strict quality standards and legal certifications.

Therapeutic areas: Infectious DiseasesNephrologyPulmonology
Modalities: Small moleculeBiologic
Industry: Contract Manufacturing Organization

Partnerships

Not specified; provides third-party manufacturing for multiple pharma brands

Beyond the preview

Go deeper on Eurocrit Labs International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eurocrit Labs International.

Explore the full profile